SEC Company Response from Quince Therapeutics, Inc. (QNCX) (CIK 0001662774) (IRLA) — May 6, 2019
Quince Therapeutics, Inc. (QNCX) (CIK 0001662774)
Date: May 6, 2019 · CIK: 0001662774 · Accession: 0001193125-19-138179
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230853
Letter
May 6, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Attn: Suzanne Hayes
Jeffrey Gabor
Joseph McCann
Re: Cortexyme, Inc. Acceleration Request
Acceleration Request
Requested Date:
May 8, 2019
Requested Time:
3:30 p.m. Eastern Time
Ladies and Gentlemen:
Cortexyme, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-230853), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Andrew D. Thorpe or Peter M. Lamb, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970, or in his absence, Mr. Lamb at (650) 289-7117.
269 East Grand Ave.
South San Francisco, CA 94080
Sincerely,
CORTEXYME, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 6, 2019 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Suzanne Hayes Jeffrey Gabor Joseph McCann Re: Cortexyme, Inc. Acceleration Request Acceleration Request Requested Date: May 8, 2019 Requested Time: 3:30 p.m. Eastern Time Ladies and Gentlemen: Cortexyme, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-230853), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Andrew D. Thorpe or Peter M. Lamb, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970, or in his absence, Mr. Lamb at (650) 289-7117. 269 East Grand Ave. South San Francisco, CA 94080 Sincerely, CORTEXYME, INC. By: /s/ Casey C. Lynch Name: Casey C. Lynch Title: President and Chief Executive Officer cc: Chris Lowe, Cortexyme, Inc. Andrew D. Thorpe, Orrick, Herrington & Sutcliffe, LLP Peter M. Lamb, Orrick, Herrington & Sutcliffe, LLP Brian J. Cuneo, Latham & Watkins LLP B. Shayne Kennedy LLP, Latham & Watkins LLP